MONTVALE, N.J., July 31, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today financial results for its 2025 fiscal second quarter ended June 30, 2025.
MONTVALE, N.J., July 17, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Thursday, July 31, 2025, at 11:00 AM Eastern Time (ET) to re
Balchem operates in diverse specialty ingredient markets, maintaining steady growth and a market cap of $5.3B. Revenue per share has grown 6% annually over a decade, but recent growth has plateaued, w
MONTVALE, N.J., June 26, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at the CJ
MONTVALE, N.J., May 28, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at the Wel
MONTVALE, N.J., May 21, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the
Balchem Corporation (NASDAQ:BCPC ) Q1 2025 Earnings Conference Call April 24, 2025 11:00 AM ET Company Participants Martin Bengtsson - CFO Ted Harris - Chairman, President & CEO Conference Call Partic

Blachem (BCPC) Lags Q1 Earnings Estimates

09:20am, Thursday, 24'th Apr 2025
Blachem (BCPC) came out with quarterly earnings of $1.22 per share, missing the Zacks Consensus Estimate of $1.25 per share. This compares to earnings of $0.89 per share a year ago.
Blachem (BCPC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
MONTVALE, N.J., April 11, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Thursday, April 24, 2025, at 11:00 AM Eastern Time (ET) to
MONTVALE, N.J., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in th
Balchem Corporation specializes in performance ingredients across nutrition, food, pharmaceuticals, and animal health, but its high P/E ratio and rising costs warrant a "Hold" rating. Q4 2024 saw mode
Balchem Corporation (NASDAQ:BCPC ) Q4 2024 Earnings Conference Call February 21, 2025 11:00 AM ET Company Participants Martin Bengtsson - CFO Ted Harris - Chairman, President and CEO Conference Call P
Blachem (BCPC) came out with quarterly earnings of $1.03 per share, missing the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $0.82 per share a year ago.
MONTVALE, N.J., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today financial results for its 2024 fiscal fourth quarter ended December 31, 2024.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE